Press Releases
Zenas BioPharma annonce la publication d’une étude de phase 2 sur l’obéxélimab, un traitement expérimental pour la maladie liée aux IgG4 (ML-IgG4), dans The Lancet Rheumatology
L’étude a montré que l’obéxélimab produisait une amélioration clinique rapide, forte et soutenue, y compris une rémission clinique complète, chez la plupart des patients atteints de ML-IgG4 active Les résultats soutiennent la poursuite du développement de l’obéxélimab pour le traitement
Zenas BioPharma Publica Fase 2 do Estudo Clínico do Obexelimabe, um Tratamento Investigativo da Doença Relacionada à IgG4 (IgG4-RD), no The Lancet Rheumatology
Estudo revelou que o obexelimabe produziu melhora clínica rápida, forte e sustentada, incluindo remissão clínica completa, na maioria dos pacientes com IgG4-RD ativa Os resultados apoiam o desenvolvimento contínuo do obexelimabe para o tratamento de IgG4-RD e potencialmente outras condições
Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology
Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM,
Conagen and Sumitomo Chemical jointly develop a new era of renewable carbon materials
Bedford, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Conagen, the bioplatform innovator and biomanufacturer, and Sumitomo Chemical, Japan’s leading chemical company, have announced to jointly develop p-hydroxystyrene (HS) and its polymer, poly p-hydroxystyrene (PHS), using a combination of biosynthesis, chemosynthesis,
WATKINS WELLNESS EXPANDS INTO SAUNA CATEGORY THROUGH THE ACQUISITION OF SAUNA360
Vista, California, July 31, 2023 (GLOBE NEWSWIRE) — Watkins Wellness, a leader in hot tubs and aquatic fitness systems, today announced the expansion of its portfolio of personal well-being products and entry into the sauna category as a result of
Les défis liés aux avions de fret neufs par rapport aux P2F, selon Gediminas Ziemelis, président du groupe Avia Solutions
DUBLIN, Irlande, 30 juill. 2023 (GLOBE NEWSWIRE) — Les années de pandémie ont généré des revenus records grâce au fret aérien. Avec une offre limitée en raison de l’immobilisation des avions de transport de passagers et une demande en hausse
Presidente do Avia Solutions Group, Gediminas Ziemelis: O desafio entre os cargueiros de fábrica e as aeronaves de passageiros convertidas em cargueiros (P2F)
DUBLIN, Irlanda, July 30, 2023 (GLOBE NEWSWIRE) — Os anos de pandemia trouxeram receitas sem precedentes do transporte aéreo de cargas. Com a oferta limitada devido à paralisação dos aviões de passageiros e a demanda em alta graças ao crescimento